Global Afamelanotide Supply, Demand and Key Producers, 2026-2032
The global Afamelanotide market size is expected to reach $ 116 million by 2032, rising at a market growth of 7.6% CAGR during the forecast period (2026-2032).
Afamelanotide is a synthetic peptide drug, an analog of alpha-melanocyte-stimulating hormone (?-MSH), used as a subcutaneous implant to prevent painful skin reactions from sun exposure in patients with the rare genetic disorder Erythropoietic Protoporphyria (EPP). It works by stimulating melanin (specifically eumelanin) production in the skin, which blocks light and reduces the severe pain, redness, and swelling caused by EPP. Administered as a small implant under the skin, it's released slowly over about two months.
Global production of afanotide is projected to reach 3,000 vials by 2025, with an average price of US$22,600 per vial. Gross profit margins typically remain at a high level of 70% to 85%.
Afamelanotide is a synthetic analog of melanocyte-stimulating hormone. Its upstream industry chain mainly consists of peptide raw materials and amino acid monomers, solid-phase synthesis resins and reagents, solvents, lyophilization excipients, sterile packaging materials, and bioanalytical testing services. The upstream focus lies in high-purity peptide synthesis and consistent quality control. Downstream demand is highly concentrated in rare disease and niche dermatology treatments, with its primary use in improving phototolerance for patients with erythropoietic protoporphyria. End users are mainly specialized hospitals, rare disease treatment centers, and reimbursement systems. Given the small and clearly defined patient population, downstream stakeholders prioritize clinical efficacy, safety, ease of administration, and long-term adherence. Payment is often supported by public insurance, special funds, or premium commercial insurance, resulting in relatively low price sensitivity but high requirements for clinical evidence. As real-world data accumulates, downstream applications are gradually expanding toward additional photosensitivity-related indications, while remaining focused on specialist channels and academic promotion.
In terms of industry trends, Afamelanotide products are moving toward indication expansion, optimized delivery methods, and stronger real-world evidence generation. Key growth drivers include supportive orphan drug policies, incentives for rare disease development, and increasing advocacy from patient organizations. Major constraints include a limited patient base that caps market size, high development and regulatory costs, complex manufacturing barriers, and strong dependence on a single core product.
This report studies the global Afamelanotide production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Afamelanotide and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Afamelanotide that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Afamelanotide total production and demand, 2021-2032, (Units)
Global Afamelanotide total production value, 2021-2032, (USD Million)
Global Afamelanotide production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Units), (based on production site)
Global Afamelanotide consumption by region & country, CAGR, 2021-2032 & (Units)
U.S. VS China: Afamelanotide domestic production, consumption, key domestic manufacturers and share
Global Afamelanotide production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Units)
Global Afamelanotide production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Units)
Global Afamelanotide production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Units)
This report profiles key players in the global Afamelanotide market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Clinuvel Pharmaceuticals, Evonik Industries, Hangzhou Go Top Peptide Biotech, Zhejiang Hengtengfu, Wepon, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Afamelanotide market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Afamelanotide Market, By Region:
1. How big is the global Afamelanotide market?
2. What is the demand of the global Afamelanotide market?
3. What is the year over year growth of the global Afamelanotide market?
4. What is the production and production value of the global Afamelanotide market?
5. Who are the key producers in the global Afamelanotide market?
6. What are the growth factors driving the market demand?
Afamelanotide is a synthetic peptide drug, an analog of alpha-melanocyte-stimulating hormone (?-MSH), used as a subcutaneous implant to prevent painful skin reactions from sun exposure in patients with the rare genetic disorder Erythropoietic Protoporphyria (EPP). It works by stimulating melanin (specifically eumelanin) production in the skin, which blocks light and reduces the severe pain, redness, and swelling caused by EPP. Administered as a small implant under the skin, it's released slowly over about two months.
Global production of afanotide is projected to reach 3,000 vials by 2025, with an average price of US$22,600 per vial. Gross profit margins typically remain at a high level of 70% to 85%.
Afamelanotide is a synthetic analog of melanocyte-stimulating hormone. Its upstream industry chain mainly consists of peptide raw materials and amino acid monomers, solid-phase synthesis resins and reagents, solvents, lyophilization excipients, sterile packaging materials, and bioanalytical testing services. The upstream focus lies in high-purity peptide synthesis and consistent quality control. Downstream demand is highly concentrated in rare disease and niche dermatology treatments, with its primary use in improving phototolerance for patients with erythropoietic protoporphyria. End users are mainly specialized hospitals, rare disease treatment centers, and reimbursement systems. Given the small and clearly defined patient population, downstream stakeholders prioritize clinical efficacy, safety, ease of administration, and long-term adherence. Payment is often supported by public insurance, special funds, or premium commercial insurance, resulting in relatively low price sensitivity but high requirements for clinical evidence. As real-world data accumulates, downstream applications are gradually expanding toward additional photosensitivity-related indications, while remaining focused on specialist channels and academic promotion.
In terms of industry trends, Afamelanotide products are moving toward indication expansion, optimized delivery methods, and stronger real-world evidence generation. Key growth drivers include supportive orphan drug policies, incentives for rare disease development, and increasing advocacy from patient organizations. Major constraints include a limited patient base that caps market size, high development and regulatory costs, complex manufacturing barriers, and strong dependence on a single core product.
This report studies the global Afamelanotide production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Afamelanotide and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Afamelanotide that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Afamelanotide total production and demand, 2021-2032, (Units)
Global Afamelanotide total production value, 2021-2032, (USD Million)
Global Afamelanotide production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Units), (based on production site)
Global Afamelanotide consumption by region & country, CAGR, 2021-2032 & (Units)
U.S. VS China: Afamelanotide domestic production, consumption, key domestic manufacturers and share
Global Afamelanotide production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Units)
Global Afamelanotide production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Units)
Global Afamelanotide production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Units)
This report profiles key players in the global Afamelanotide market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Clinuvel Pharmaceuticals, Evonik Industries, Hangzhou Go Top Peptide Biotech, Zhejiang Hengtengfu, Wepon, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Afamelanotide market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Afamelanotide Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Subcutaneous Implants
- Injectables
- Transdermal Patches
- Oral Preparations
- Topical Preparations
- ?-MSH Analogs
- Acetate Derivatives
- Free Peptide Derivatives
- Long-Acting Modified Derivatives
- MC1R Selective Agonists
- Melanin Synthesis Stimulants
- Anti-Inflammatory Agents
- Neuroprotective Agents
- Hematologic Disorders
- Skin Pigmentary Disorders
- Acute Diseases
- Autoimmune Diseases
- Neurodegenerative Diseases
- Clinuvel Pharmaceuticals
- Evonik Industries
- Hangzhou Go Top Peptide Biotech
- Zhejiang Hengtengfu
- Wepon
1. How big is the global Afamelanotide market?
2. What is the demand of the global Afamelanotide market?
3. What is the year over year growth of the global Afamelanotide market?
4. What is the production and production value of the global Afamelanotide market?
5. Who are the key producers in the global Afamelanotide market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Afamelanotide Introduction
1.2 World Afamelanotide Supply & Forecast
1.2.1 World Afamelanotide Production Value (2021 & 2025 & 2032)
1.2.2 World Afamelanotide Production (2021-2032)
1.2.3 World Afamelanotide Pricing Trends (2021-2032)
1.3 World Afamelanotide Production by Region (Based on Production Site)
1.3.1 World Afamelanotide Production Value by Region (2021-2032)
1.3.2 World Afamelanotide Production by Region (2021-2032)
1.3.3 World Afamelanotide Average Price by Region (2021-2032)
1.3.4 North America Afamelanotide Production (2021-2032)
1.3.5 Europe Afamelanotide Production (2021-2032)
1.3.6 China Afamelanotide Production (2021-2032)
1.3.7 Japan Afamelanotide Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Afamelanotide Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Afamelanotide Major Market Trends
2 DEMAND SUMMARY
2.1 World Afamelanotide Demand (2021-2032)
2.2 World Afamelanotide Consumption by Region
2.2.1 World Afamelanotide Consumption by Region (2021-2026)
2.2.2 World Afamelanotide Consumption Forecast by Region (2027-2032)
2.3 United States Afamelanotide Consumption (2021-2032)
2.4 China Afamelanotide Consumption (2021-2032)
2.5 Europe Afamelanotide Consumption (2021-2032)
2.6 Japan Afamelanotide Consumption (2021-2032)
2.7 South Korea Afamelanotide Consumption (2021-2032)
2.8 ASEAN Afamelanotide Consumption (2021-2032)
2.9 India Afamelanotide Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Afamelanotide Production Value by Manufacturer (2021-2026)
3.2 World Afamelanotide Production by Manufacturer (2021-2026)
3.3 World Afamelanotide Average Price by Manufacturer (2021-2026)
3.4 Afamelanotide Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Afamelanotide Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Afamelanotide in 2025
3.5.3 Global Concentration Ratios (CR8) for Afamelanotide in 2025
3.6 Afamelanotide Market: Overall Company Footprint Analysis
3.6.1 Afamelanotide Market: Region Footprint
3.6.2 Afamelanotide Market: Company Product Type Footprint
3.6.3 Afamelanotide Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Afamelanotide Production Value Comparison
4.1.1 United States VS China: Afamelanotide Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Afamelanotide Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Afamelanotide Production Comparison
4.2.1 United States VS China: Afamelanotide Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Afamelanotide Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Afamelanotide Consumption Comparison
4.3.1 United States VS China: Afamelanotide Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Afamelanotide Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Afamelanotide Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Afamelanotide Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Afamelanotide Production Value (2021-2026)
4.4.3 United States Based Manufacturers Afamelanotide Production (2021-2026)
4.5 China Based Afamelanotide Manufacturers and Market Share
4.5.1 China Based Afamelanotide Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Afamelanotide Production Value (2021-2026)
4.5.3 China Based Manufacturers Afamelanotide Production (2021-2026)
4.6 Rest of World Based Afamelanotide Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Afamelanotide Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Afamelanotide Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Afamelanotide Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Afamelanotide Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Subcutaneous Implants
5.2.2 Injectables
5.2.3 Transdermal Patches
5.2.4 Oral Preparations
5.2.5 Topical Preparations
5.3 Market Segment by Type
5.3.1 World Afamelanotide Production by Type (2021-2032)
5.3.2 World Afamelanotide Production Value by Type (2021-2032)
5.3.3 World Afamelanotide Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY CHEMICAL STRUCTURE
6.1 World Afamelanotide Market Size Overview by Chemical Structure: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Chemical Structure
6.2.1 ?-MSH Analogs
6.2.2 Acetate Derivatives
6.2.3 Free Peptide Derivatives
6.2.4 Long-Acting Modified Derivatives
6.3 Market Segment by Chemical Structure
6.3.1 World Afamelanotide Production by Chemical Structure (2021-2032)
6.3.2 World Afamelanotide Production Value by Chemical Structure (2021-2032)
6.3.3 World Afamelanotide Average Price by Chemical Structure (2021-2032)
7 MARKET ANALYSIS BY PHARMACOLOGICAL EFFECTS
7.1 World Afamelanotide Market Size Overview by Pharmacological Effects: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Pharmacological Effects
7.2.1 MC1R Selective Agonists
7.2.2 Melanin Synthesis Stimulants
7.2.3 Anti-Inflammatory Agents
7.2.4 Neuroprotective Agents
7.3 Market Segment by Pharmacological Effects
7.3.1 World Afamelanotide Production by Pharmacological Effects (2021-2032)
7.3.2 World Afamelanotide Production Value by Pharmacological Effects (2021-2032)
7.3.3 World Afamelanotide Average Price by Pharmacological Effects (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Afamelanotide Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hematologic Disorders
8.2.2 Skin Pigmentary Disorders
8.2.3 Acute Diseases
8.2.4 Autoimmune Diseases
8.2.5 Neurodegenerative Diseases
8.3 Market Segment by Application
8.3.1 World Afamelanotide Production by Application (2021-2032)
8.3.2 World Afamelanotide Production Value by Application (2021-2032)
8.3.3 World Afamelanotide Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Clinuvel Pharmaceuticals
9.1.1 Clinuvel Pharmaceuticals Details
9.1.2 Clinuvel Pharmaceuticals Major Business
9.1.3 Clinuvel Pharmaceuticals Afamelanotide Product and Services
9.1.4 Clinuvel Pharmaceuticals Afamelanotide Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Clinuvel Pharmaceuticals Recent Developments/Updates
9.1.6 Clinuvel Pharmaceuticals Competitive Strengths & Weaknesses
9.2 Evonik Industries
9.2.1 Evonik Industries Details
9.2.2 Evonik Industries Major Business
9.2.3 Evonik Industries Afamelanotide Product and Services
9.2.4 Evonik Industries Afamelanotide Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Evonik Industries Recent Developments/Updates
9.2.6 Evonik Industries Competitive Strengths & Weaknesses
9.3 Hangzhou Go Top Peptide Biotech
9.3.1 Hangzhou Go Top Peptide Biotech Details
9.3.2 Hangzhou Go Top Peptide Biotech Major Business
9.3.3 Hangzhou Go Top Peptide Biotech Afamelanotide Product and Services
9.3.4 Hangzhou Go Top Peptide Biotech Afamelanotide Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Hangzhou Go Top Peptide Biotech Recent Developments/Updates
9.3.6 Hangzhou Go Top Peptide Biotech Competitive Strengths & Weaknesses
9.4 Zhejiang Hengtengfu
9.4.1 Zhejiang Hengtengfu Details
9.4.2 Zhejiang Hengtengfu Major Business
9.4.3 Zhejiang Hengtengfu Afamelanotide Product and Services
9.4.4 Zhejiang Hengtengfu Afamelanotide Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Zhejiang Hengtengfu Recent Developments/Updates
9.4.6 Zhejiang Hengtengfu Competitive Strengths & Weaknesses
9.5 Wepon
9.5.1 Wepon Details
9.5.2 Wepon Major Business
9.5.3 Wepon Afamelanotide Product and Services
9.5.4 Wepon Afamelanotide Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Wepon Recent Developments/Updates
9.5.6 Wepon Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Afamelanotide Industry Chain
10.2 Afamelanotide Upstream Analysis
10.2.1 Afamelanotide Core Raw Materials
10.2.2 Main Manufacturers of Afamelanotide Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Afamelanotide Production Mode
10.6 Afamelanotide Procurement Model
10.7 Afamelanotide Industry Sales Model and Sales Channels
10.7.1 Afamelanotide Sales Model
10.7.2 Afamelanotide Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Afamelanotide Introduction
1.2 World Afamelanotide Supply & Forecast
1.2.1 World Afamelanotide Production Value (2021 & 2025 & 2032)
1.2.2 World Afamelanotide Production (2021-2032)
1.2.3 World Afamelanotide Pricing Trends (2021-2032)
1.3 World Afamelanotide Production by Region (Based on Production Site)
1.3.1 World Afamelanotide Production Value by Region (2021-2032)
1.3.2 World Afamelanotide Production by Region (2021-2032)
1.3.3 World Afamelanotide Average Price by Region (2021-2032)
1.3.4 North America Afamelanotide Production (2021-2032)
1.3.5 Europe Afamelanotide Production (2021-2032)
1.3.6 China Afamelanotide Production (2021-2032)
1.3.7 Japan Afamelanotide Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Afamelanotide Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Afamelanotide Major Market Trends
2 DEMAND SUMMARY
2.1 World Afamelanotide Demand (2021-2032)
2.2 World Afamelanotide Consumption by Region
2.2.1 World Afamelanotide Consumption by Region (2021-2026)
2.2.2 World Afamelanotide Consumption Forecast by Region (2027-2032)
2.3 United States Afamelanotide Consumption (2021-2032)
2.4 China Afamelanotide Consumption (2021-2032)
2.5 Europe Afamelanotide Consumption (2021-2032)
2.6 Japan Afamelanotide Consumption (2021-2032)
2.7 South Korea Afamelanotide Consumption (2021-2032)
2.8 ASEAN Afamelanotide Consumption (2021-2032)
2.9 India Afamelanotide Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Afamelanotide Production Value by Manufacturer (2021-2026)
3.2 World Afamelanotide Production by Manufacturer (2021-2026)
3.3 World Afamelanotide Average Price by Manufacturer (2021-2026)
3.4 Afamelanotide Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Afamelanotide Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Afamelanotide in 2025
3.5.3 Global Concentration Ratios (CR8) for Afamelanotide in 2025
3.6 Afamelanotide Market: Overall Company Footprint Analysis
3.6.1 Afamelanotide Market: Region Footprint
3.6.2 Afamelanotide Market: Company Product Type Footprint
3.6.3 Afamelanotide Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Afamelanotide Production Value Comparison
4.1.1 United States VS China: Afamelanotide Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Afamelanotide Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Afamelanotide Production Comparison
4.2.1 United States VS China: Afamelanotide Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Afamelanotide Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Afamelanotide Consumption Comparison
4.3.1 United States VS China: Afamelanotide Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Afamelanotide Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Afamelanotide Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Afamelanotide Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Afamelanotide Production Value (2021-2026)
4.4.3 United States Based Manufacturers Afamelanotide Production (2021-2026)
4.5 China Based Afamelanotide Manufacturers and Market Share
4.5.1 China Based Afamelanotide Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Afamelanotide Production Value (2021-2026)
4.5.3 China Based Manufacturers Afamelanotide Production (2021-2026)
4.6 Rest of World Based Afamelanotide Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Afamelanotide Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Afamelanotide Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Afamelanotide Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Afamelanotide Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Subcutaneous Implants
5.2.2 Injectables
5.2.3 Transdermal Patches
5.2.4 Oral Preparations
5.2.5 Topical Preparations
5.3 Market Segment by Type
5.3.1 World Afamelanotide Production by Type (2021-2032)
5.3.2 World Afamelanotide Production Value by Type (2021-2032)
5.3.3 World Afamelanotide Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY CHEMICAL STRUCTURE
6.1 World Afamelanotide Market Size Overview by Chemical Structure: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Chemical Structure
6.2.1 ?-MSH Analogs
6.2.2 Acetate Derivatives
6.2.3 Free Peptide Derivatives
6.2.4 Long-Acting Modified Derivatives
6.3 Market Segment by Chemical Structure
6.3.1 World Afamelanotide Production by Chemical Structure (2021-2032)
6.3.2 World Afamelanotide Production Value by Chemical Structure (2021-2032)
6.3.3 World Afamelanotide Average Price by Chemical Structure (2021-2032)
7 MARKET ANALYSIS BY PHARMACOLOGICAL EFFECTS
7.1 World Afamelanotide Market Size Overview by Pharmacological Effects: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Pharmacological Effects
7.2.1 MC1R Selective Agonists
7.2.2 Melanin Synthesis Stimulants
7.2.3 Anti-Inflammatory Agents
7.2.4 Neuroprotective Agents
7.3 Market Segment by Pharmacological Effects
7.3.1 World Afamelanotide Production by Pharmacological Effects (2021-2032)
7.3.2 World Afamelanotide Production Value by Pharmacological Effects (2021-2032)
7.3.3 World Afamelanotide Average Price by Pharmacological Effects (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Afamelanotide Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hematologic Disorders
8.2.2 Skin Pigmentary Disorders
8.2.3 Acute Diseases
8.2.4 Autoimmune Diseases
8.2.5 Neurodegenerative Diseases
8.3 Market Segment by Application
8.3.1 World Afamelanotide Production by Application (2021-2032)
8.3.2 World Afamelanotide Production Value by Application (2021-2032)
8.3.3 World Afamelanotide Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Clinuvel Pharmaceuticals
9.1.1 Clinuvel Pharmaceuticals Details
9.1.2 Clinuvel Pharmaceuticals Major Business
9.1.3 Clinuvel Pharmaceuticals Afamelanotide Product and Services
9.1.4 Clinuvel Pharmaceuticals Afamelanotide Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Clinuvel Pharmaceuticals Recent Developments/Updates
9.1.6 Clinuvel Pharmaceuticals Competitive Strengths & Weaknesses
9.2 Evonik Industries
9.2.1 Evonik Industries Details
9.2.2 Evonik Industries Major Business
9.2.3 Evonik Industries Afamelanotide Product and Services
9.2.4 Evonik Industries Afamelanotide Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Evonik Industries Recent Developments/Updates
9.2.6 Evonik Industries Competitive Strengths & Weaknesses
9.3 Hangzhou Go Top Peptide Biotech
9.3.1 Hangzhou Go Top Peptide Biotech Details
9.3.2 Hangzhou Go Top Peptide Biotech Major Business
9.3.3 Hangzhou Go Top Peptide Biotech Afamelanotide Product and Services
9.3.4 Hangzhou Go Top Peptide Biotech Afamelanotide Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Hangzhou Go Top Peptide Biotech Recent Developments/Updates
9.3.6 Hangzhou Go Top Peptide Biotech Competitive Strengths & Weaknesses
9.4 Zhejiang Hengtengfu
9.4.1 Zhejiang Hengtengfu Details
9.4.2 Zhejiang Hengtengfu Major Business
9.4.3 Zhejiang Hengtengfu Afamelanotide Product and Services
9.4.4 Zhejiang Hengtengfu Afamelanotide Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Zhejiang Hengtengfu Recent Developments/Updates
9.4.6 Zhejiang Hengtengfu Competitive Strengths & Weaknesses
9.5 Wepon
9.5.1 Wepon Details
9.5.2 Wepon Major Business
9.5.3 Wepon Afamelanotide Product and Services
9.5.4 Wepon Afamelanotide Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Wepon Recent Developments/Updates
9.5.6 Wepon Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Afamelanotide Industry Chain
10.2 Afamelanotide Upstream Analysis
10.2.1 Afamelanotide Core Raw Materials
10.2.2 Main Manufacturers of Afamelanotide Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Afamelanotide Production Mode
10.6 Afamelanotide Procurement Model
10.7 Afamelanotide Industry Sales Model and Sales Channels
10.7.1 Afamelanotide Sales Model
10.7.2 Afamelanotide Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Afamelanotide Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Afamelanotide Production Value by Region (2021-2026) & (USD Million)
Table 3. World Afamelanotide Production Value by Region (2027-2032) & (USD Million)
Table 4. World Afamelanotide Production Value Market Share by Region (2021-2026)
Table 5. World Afamelanotide Production Value Market Share by Region (2027-2032)
Table 6. World Afamelanotide Production by Region (2021-2026) & (Units)
Table 7. World Afamelanotide Production by Region (2027-2032) & (Units)
Table 8. World Afamelanotide Production Market Share by Region (2021-2026)
Table 9. World Afamelanotide Production Market Share by Region (2027-2032)
Table 10. World Afamelanotide Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Afamelanotide Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Afamelanotide Major Market Trends
Table 13. World Afamelanotide Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Units)
Table 14. World Afamelanotide Consumption by Region (2021-2026) & (Units)
Table 15. World Afamelanotide Consumption Forecast by Region (2027-2032) & (Units)
Table 16. World Afamelanotide Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Afamelanotide Producers in 2025
Table 18. World Afamelanotide Production by Manufacturer (2021-2026) & (Units)
Table 19. Production Market Share of Key Afamelanotide Producers in 2025
Table 20. World Afamelanotide Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Afamelanotide Company Evaluation Quadrant
Table 22. World Afamelanotide Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Afamelanotide Production Site of Key Manufacturer
Table 24. Afamelanotide Market: Company Product Type Footprint
Table 25. Afamelanotide Market: Company Product Application Footprint
Table 26. Afamelanotide Competitive Factors
Table 27. Afamelanotide New Entrant and Capacity Expansion Plans
Table 28. Afamelanotide Mergers & Acquisitions Activity
Table 29. United States VS China Afamelanotide Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Afamelanotide Production Comparison, (2021 & 2025 & 2032) & (Units)
Table 31. United States VS China Afamelanotide Consumption Comparison, (2021 & 2025 & 2032) & (Units)
Table 32. United States Based Afamelanotide Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Afamelanotide Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Afamelanotide Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Afamelanotide Production (2021-2026) & (Units)
Table 36. United States Based Manufacturers Afamelanotide Production Market Share (2021-2026)
Table 37. China Based Afamelanotide Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Afamelanotide Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Afamelanotide Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Afamelanotide Production, (2021-2026) & (Units)
Table 41. China Based Manufacturers Afamelanotide Production Market Share (2021-2026)
Table 42. Rest of World Based Afamelanotide Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Afamelanotide Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Afamelanotide Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Afamelanotide Production, (2021-2026) & (Units)
Table 46. Rest of World Based Manufacturers Afamelanotide Production Market Share (2021-2026)
Table 47. World Afamelanotide Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Afamelanotide Production by Type (2021-2026) & (Units)
Table 49. World Afamelanotide Production by Type (2027-2032) & (Units)
Table 50. World Afamelanotide Production Value by Type (2021-2026) & (USD Million)
Table 51. World Afamelanotide Production Value by Type (2027-2032) & (USD Million)
Table 52. World Afamelanotide Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Afamelanotide Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Afamelanotide Production Value by Chemical Structure, (USD Million), 2021 & 2025 & 2032
Table 55. World Afamelanotide Production by Chemical Structure (2021-2026) & (Units)
Table 56. World Afamelanotide Production by Chemical Structure (2027-2032) & (Units)
Table 57. World Afamelanotide Production Value by Chemical Structure (2021-2026) & (USD Million)
Table 58. World Afamelanotide Production Value by Chemical Structure (2027-2032) & (USD Million)
Table 59. World Afamelanotide Average Price by Chemical Structure (2021-2026) & (US$/Unit)
Table 60. World Afamelanotide Average Price by Chemical Structure (2027-2032) & (US$/Unit)
Table 61. World Afamelanotide Production Value by Pharmacological Effects, (USD Million), 2021 & 2025 & 2032
Table 62. World Afamelanotide Production by Pharmacological Effects (2021-2026) & (Units)
Table 63. World Afamelanotide Production by Pharmacological Effects (2027-2032) & (Units)
Table 64. World Afamelanotide Production Value by Pharmacological Effects (2021-2026) & (USD Million)
Table 65. World Afamelanotide Production Value by Pharmacological Effects (2027-2032) & (USD Million)
Table 66. World Afamelanotide Average Price by Pharmacological Effects (2021-2026) & (US$/Unit)
Table 67. World Afamelanotide Average Price by Pharmacological Effects (2027-2032) & (US$/Unit)
Table 68. World Afamelanotide Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Afamelanotide Production by Application (2021-2026) & (Units)
Table 70. World Afamelanotide Production by Application (2027-2032) & (Units)
Table 71. World Afamelanotide Production Value by Application (2021-2026) & (USD Million)
Table 72. World Afamelanotide Production Value by Application (2027-2032) & (USD Million)
Table 73. World Afamelanotide Average Price by Application (2021-2026) & (US$/Unit)
Table 74. World Afamelanotide Average Price by Application (2027-2032) & (US$/Unit)
Table 75. Clinuvel Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 76. Clinuvel Pharmaceuticals Major Business
Table 77. Clinuvel Pharmaceuticals Afamelanotide Product and Services
Table 78. Clinuvel Pharmaceuticals Afamelanotide Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Clinuvel Pharmaceuticals Recent Developments/Updates
Table 80. Clinuvel Pharmaceuticals Competitive Strengths & Weaknesses
Table 81. Evonik Industries Basic Information, Manufacturing Base and Competitors
Table 82. Evonik Industries Major Business
Table 83. Evonik Industries Afamelanotide Product and Services
Table 84. Evonik Industries Afamelanotide Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Evonik Industries Recent Developments/Updates
Table 86. Evonik Industries Competitive Strengths & Weaknesses
Table 87. Hangzhou Go Top Peptide Biotech Basic Information, Manufacturing Base and Competitors
Table 88. Hangzhou Go Top Peptide Biotech Major Business
Table 89. Hangzhou Go Top Peptide Biotech Afamelanotide Product and Services
Table 90. Hangzhou Go Top Peptide Biotech Afamelanotide Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Hangzhou Go Top Peptide Biotech Recent Developments/Updates
Table 92. Hangzhou Go Top Peptide Biotech Competitive Strengths & Weaknesses
Table 93. Zhejiang Hengtengfu Basic Information, Manufacturing Base and Competitors
Table 94. Zhejiang Hengtengfu Major Business
Table 95. Zhejiang Hengtengfu Afamelanotide Product and Services
Table 96. Zhejiang Hengtengfu Afamelanotide Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Zhejiang Hengtengfu Recent Developments/Updates
Table 98. Zhejiang Hengtengfu Competitive Strengths & Weaknesses
Table 99. Wepon Basic Information, Manufacturing Base and Competitors
Table 100. Wepon Major Business
Table 101. Wepon Afamelanotide Product and Services
Table 102. Wepon Afamelanotide Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Wepon Recent Developments/Updates
Table 104. Wepon Competitive Strengths & Weaknesses
Table 105. Global Key Players of Afamelanotide Upstream (Raw Materials)
Table 106. Global Afamelanotide Typical Customers
Table 107. Afamelanotide Typical Distributors
Table 1. World Afamelanotide Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Afamelanotide Production Value by Region (2021-2026) & (USD Million)
Table 3. World Afamelanotide Production Value by Region (2027-2032) & (USD Million)
Table 4. World Afamelanotide Production Value Market Share by Region (2021-2026)
Table 5. World Afamelanotide Production Value Market Share by Region (2027-2032)
Table 6. World Afamelanotide Production by Region (2021-2026) & (Units)
Table 7. World Afamelanotide Production by Region (2027-2032) & (Units)
Table 8. World Afamelanotide Production Market Share by Region (2021-2026)
Table 9. World Afamelanotide Production Market Share by Region (2027-2032)
Table 10. World Afamelanotide Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Afamelanotide Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Afamelanotide Major Market Trends
Table 13. World Afamelanotide Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Units)
Table 14. World Afamelanotide Consumption by Region (2021-2026) & (Units)
Table 15. World Afamelanotide Consumption Forecast by Region (2027-2032) & (Units)
Table 16. World Afamelanotide Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Afamelanotide Producers in 2025
Table 18. World Afamelanotide Production by Manufacturer (2021-2026) & (Units)
Table 19. Production Market Share of Key Afamelanotide Producers in 2025
Table 20. World Afamelanotide Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Afamelanotide Company Evaluation Quadrant
Table 22. World Afamelanotide Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Afamelanotide Production Site of Key Manufacturer
Table 24. Afamelanotide Market: Company Product Type Footprint
Table 25. Afamelanotide Market: Company Product Application Footprint
Table 26. Afamelanotide Competitive Factors
Table 27. Afamelanotide New Entrant and Capacity Expansion Plans
Table 28. Afamelanotide Mergers & Acquisitions Activity
Table 29. United States VS China Afamelanotide Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Afamelanotide Production Comparison, (2021 & 2025 & 2032) & (Units)
Table 31. United States VS China Afamelanotide Consumption Comparison, (2021 & 2025 & 2032) & (Units)
Table 32. United States Based Afamelanotide Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Afamelanotide Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Afamelanotide Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Afamelanotide Production (2021-2026) & (Units)
Table 36. United States Based Manufacturers Afamelanotide Production Market Share (2021-2026)
Table 37. China Based Afamelanotide Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Afamelanotide Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Afamelanotide Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Afamelanotide Production, (2021-2026) & (Units)
Table 41. China Based Manufacturers Afamelanotide Production Market Share (2021-2026)
Table 42. Rest of World Based Afamelanotide Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Afamelanotide Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Afamelanotide Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Afamelanotide Production, (2021-2026) & (Units)
Table 46. Rest of World Based Manufacturers Afamelanotide Production Market Share (2021-2026)
Table 47. World Afamelanotide Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Afamelanotide Production by Type (2021-2026) & (Units)
Table 49. World Afamelanotide Production by Type (2027-2032) & (Units)
Table 50. World Afamelanotide Production Value by Type (2021-2026) & (USD Million)
Table 51. World Afamelanotide Production Value by Type (2027-2032) & (USD Million)
Table 52. World Afamelanotide Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Afamelanotide Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Afamelanotide Production Value by Chemical Structure, (USD Million), 2021 & 2025 & 2032
Table 55. World Afamelanotide Production by Chemical Structure (2021-2026) & (Units)
Table 56. World Afamelanotide Production by Chemical Structure (2027-2032) & (Units)
Table 57. World Afamelanotide Production Value by Chemical Structure (2021-2026) & (USD Million)
Table 58. World Afamelanotide Production Value by Chemical Structure (2027-2032) & (USD Million)
Table 59. World Afamelanotide Average Price by Chemical Structure (2021-2026) & (US$/Unit)
Table 60. World Afamelanotide Average Price by Chemical Structure (2027-2032) & (US$/Unit)
Table 61. World Afamelanotide Production Value by Pharmacological Effects, (USD Million), 2021 & 2025 & 2032
Table 62. World Afamelanotide Production by Pharmacological Effects (2021-2026) & (Units)
Table 63. World Afamelanotide Production by Pharmacological Effects (2027-2032) & (Units)
Table 64. World Afamelanotide Production Value by Pharmacological Effects (2021-2026) & (USD Million)
Table 65. World Afamelanotide Production Value by Pharmacological Effects (2027-2032) & (USD Million)
Table 66. World Afamelanotide Average Price by Pharmacological Effects (2021-2026) & (US$/Unit)
Table 67. World Afamelanotide Average Price by Pharmacological Effects (2027-2032) & (US$/Unit)
Table 68. World Afamelanotide Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Afamelanotide Production by Application (2021-2026) & (Units)
Table 70. World Afamelanotide Production by Application (2027-2032) & (Units)
Table 71. World Afamelanotide Production Value by Application (2021-2026) & (USD Million)
Table 72. World Afamelanotide Production Value by Application (2027-2032) & (USD Million)
Table 73. World Afamelanotide Average Price by Application (2021-2026) & (US$/Unit)
Table 74. World Afamelanotide Average Price by Application (2027-2032) & (US$/Unit)
Table 75. Clinuvel Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 76. Clinuvel Pharmaceuticals Major Business
Table 77. Clinuvel Pharmaceuticals Afamelanotide Product and Services
Table 78. Clinuvel Pharmaceuticals Afamelanotide Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Clinuvel Pharmaceuticals Recent Developments/Updates
Table 80. Clinuvel Pharmaceuticals Competitive Strengths & Weaknesses
Table 81. Evonik Industries Basic Information, Manufacturing Base and Competitors
Table 82. Evonik Industries Major Business
Table 83. Evonik Industries Afamelanotide Product and Services
Table 84. Evonik Industries Afamelanotide Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Evonik Industries Recent Developments/Updates
Table 86. Evonik Industries Competitive Strengths & Weaknesses
Table 87. Hangzhou Go Top Peptide Biotech Basic Information, Manufacturing Base and Competitors
Table 88. Hangzhou Go Top Peptide Biotech Major Business
Table 89. Hangzhou Go Top Peptide Biotech Afamelanotide Product and Services
Table 90. Hangzhou Go Top Peptide Biotech Afamelanotide Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Hangzhou Go Top Peptide Biotech Recent Developments/Updates
Table 92. Hangzhou Go Top Peptide Biotech Competitive Strengths & Weaknesses
Table 93. Zhejiang Hengtengfu Basic Information, Manufacturing Base and Competitors
Table 94. Zhejiang Hengtengfu Major Business
Table 95. Zhejiang Hengtengfu Afamelanotide Product and Services
Table 96. Zhejiang Hengtengfu Afamelanotide Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Zhejiang Hengtengfu Recent Developments/Updates
Table 98. Zhejiang Hengtengfu Competitive Strengths & Weaknesses
Table 99. Wepon Basic Information, Manufacturing Base and Competitors
Table 100. Wepon Major Business
Table 101. Wepon Afamelanotide Product and Services
Table 102. Wepon Afamelanotide Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Wepon Recent Developments/Updates
Table 104. Wepon Competitive Strengths & Weaknesses
Table 105. Global Key Players of Afamelanotide Upstream (Raw Materials)
Table 106. Global Afamelanotide Typical Customers
Table 107. Afamelanotide Typical Distributors
LIST OF FIGURES
Figure 1. Afamelanotide Picture
Figure 2. World Afamelanotide Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Afamelanotide Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Afamelanotide Production (2021-2032) & (Units)
Figure 5. World Afamelanotide Average Price (2021-2032) & (US$/Unit)
Figure 6. World Afamelanotide Production Value Market Share by Region (2021-2032)
Figure 7. World Afamelanotide Production Market Share by Region (2021-2032)
Figure 8. North America Afamelanotide Production (2021-2032) & (Units)
Figure 9. Europe Afamelanotide Production (2021-2032) & (Units)
Figure 10. China Afamelanotide Production (2021-2032) & (Units)
Figure 11. Japan Afamelanotide Production (2021-2032) & (Units)
Figure 12. Afamelanotide Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Afamelanotide Consumption (2021-2032) & (Units)
Figure 15. World Afamelanotide Consumption Market Share by Region (2021-2032)
Figure 16. United States Afamelanotide Consumption (2021-2032) & (Units)
Figure 17. China Afamelanotide Consumption (2021-2032) & (Units)
Figure 18. Europe Afamelanotide Consumption (2021-2032) & (Units)
Figure 19. Japan Afamelanotide Consumption (2021-2032) & (Units)
Figure 20. South Korea Afamelanotide Consumption (2021-2032) & (Units)
Figure 21. ASEAN Afamelanotide Consumption (2021-2032) & (Units)
Figure 22. India Afamelanotide Consumption (2021-2032) & (Units)
Figure 23. Producer Shipments of Afamelanotide by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Afamelanotide Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Afamelanotide Markets in 2025
Figure 26. United States VS China: Afamelanotide Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Afamelanotide Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Afamelanotide Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Afamelanotide Production Market Share 2025
Figure 30. China Based Manufacturers Afamelanotide Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Afamelanotide Production Market Share 2025
Figure 32. World Afamelanotide Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Afamelanotide Production Value Market Share by Type in 2025
Figure 34. Subcutaneous Implants
Figure 35. Injectables
Figure 36. Transdermal Patches
Figure 37. Oral Preparations
Figure 38. Topical Preparations
Figure 39. World Afamelanotide Production Market Share by Type (2021-2032)
Figure 40. World Afamelanotide Production Value Market Share by Type (2021-2032)
Figure 41. World Afamelanotide Average Price by Type (2021-2032) & (US$/Unit)
Figure 42. World Afamelanotide Production Value by Chemical Structure, (USD Million), 2021 & 2025 & 2032
Figure 43. World Afamelanotide Production Value Market Share by Chemical Structure in 2025
Figure 44. ?-MSH Analogs
Figure 45. Acetate Derivatives
Figure 46. Free Peptide Derivatives
Figure 47. Long-Acting Modified Derivatives
Figure 48. World Afamelanotide Production Market Share by Chemical Structure (2021-2032)
Figure 49. World Afamelanotide Production Value Market Share by Chemical Structure (2021-2032)
Figure 50. World Afamelanotide Average Price by Chemical Structure (2021-2032) & (US$/Unit)
Figure 51. World Afamelanotide Production Value by Pharmacological Effects, (USD Million), 2021 & 2025 & 2032
Figure 52. World Afamelanotide Production Value Market Share by Pharmacological Effects in 2025
Figure 53. MC1R Selective Agonists
Figure 54. Melanin Synthesis Stimulants
Figure 55. Anti-Inflammatory Agents
Figure 56. Neuroprotective Agents
Figure 57. World Afamelanotide Production Market Share by Pharmacological Effects (2021-2032)
Figure 58. World Afamelanotide Production Value Market Share by Pharmacological Effects (2021-2032)
Figure 59. World Afamelanotide Average Price by Pharmacological Effects (2021-2032) & (US$/Unit)
Figure 60. World Afamelanotide Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 61. World Afamelanotide Production Value Market Share by Application in 2025
Figure 62. Hematologic Disorders
Figure 63. Skin Pigmentary Disorders
Figure 64. Acute Diseases
Figure 65. Autoimmune Diseases
Figure 66. Neurodegenerative Diseases
Figure 67. World Afamelanotide Production Market Share by Application (2021-2032)
Figure 68. World Afamelanotide Production Value Market Share by Application (2021-2032)
Figure 69. World Afamelanotide Average Price by Application (2021-2032) & (US$/Unit)
Figure 70. Afamelanotide Industry Chain
Figure 71. Afamelanotide Procurement Model
Figure 72. Afamelanotide Sales Model
Figure 73. Afamelanotide Sales Channels, Direct Sales, and Distribution
Figure 74. Methodology
Figure 75. Research Process and Data Source
Figure 1. Afamelanotide Picture
Figure 2. World Afamelanotide Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Afamelanotide Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Afamelanotide Production (2021-2032) & (Units)
Figure 5. World Afamelanotide Average Price (2021-2032) & (US$/Unit)
Figure 6. World Afamelanotide Production Value Market Share by Region (2021-2032)
Figure 7. World Afamelanotide Production Market Share by Region (2021-2032)
Figure 8. North America Afamelanotide Production (2021-2032) & (Units)
Figure 9. Europe Afamelanotide Production (2021-2032) & (Units)
Figure 10. China Afamelanotide Production (2021-2032) & (Units)
Figure 11. Japan Afamelanotide Production (2021-2032) & (Units)
Figure 12. Afamelanotide Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Afamelanotide Consumption (2021-2032) & (Units)
Figure 15. World Afamelanotide Consumption Market Share by Region (2021-2032)
Figure 16. United States Afamelanotide Consumption (2021-2032) & (Units)
Figure 17. China Afamelanotide Consumption (2021-2032) & (Units)
Figure 18. Europe Afamelanotide Consumption (2021-2032) & (Units)
Figure 19. Japan Afamelanotide Consumption (2021-2032) & (Units)
Figure 20. South Korea Afamelanotide Consumption (2021-2032) & (Units)
Figure 21. ASEAN Afamelanotide Consumption (2021-2032) & (Units)
Figure 22. India Afamelanotide Consumption (2021-2032) & (Units)
Figure 23. Producer Shipments of Afamelanotide by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Afamelanotide Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Afamelanotide Markets in 2025
Figure 26. United States VS China: Afamelanotide Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Afamelanotide Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Afamelanotide Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Afamelanotide Production Market Share 2025
Figure 30. China Based Manufacturers Afamelanotide Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Afamelanotide Production Market Share 2025
Figure 32. World Afamelanotide Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Afamelanotide Production Value Market Share by Type in 2025
Figure 34. Subcutaneous Implants
Figure 35. Injectables
Figure 36. Transdermal Patches
Figure 37. Oral Preparations
Figure 38. Topical Preparations
Figure 39. World Afamelanotide Production Market Share by Type (2021-2032)
Figure 40. World Afamelanotide Production Value Market Share by Type (2021-2032)
Figure 41. World Afamelanotide Average Price by Type (2021-2032) & (US$/Unit)
Figure 42. World Afamelanotide Production Value by Chemical Structure, (USD Million), 2021 & 2025 & 2032
Figure 43. World Afamelanotide Production Value Market Share by Chemical Structure in 2025
Figure 44. ?-MSH Analogs
Figure 45. Acetate Derivatives
Figure 46. Free Peptide Derivatives
Figure 47. Long-Acting Modified Derivatives
Figure 48. World Afamelanotide Production Market Share by Chemical Structure (2021-2032)
Figure 49. World Afamelanotide Production Value Market Share by Chemical Structure (2021-2032)
Figure 50. World Afamelanotide Average Price by Chemical Structure (2021-2032) & (US$/Unit)
Figure 51. World Afamelanotide Production Value by Pharmacological Effects, (USD Million), 2021 & 2025 & 2032
Figure 52. World Afamelanotide Production Value Market Share by Pharmacological Effects in 2025
Figure 53. MC1R Selective Agonists
Figure 54. Melanin Synthesis Stimulants
Figure 55. Anti-Inflammatory Agents
Figure 56. Neuroprotective Agents
Figure 57. World Afamelanotide Production Market Share by Pharmacological Effects (2021-2032)
Figure 58. World Afamelanotide Production Value Market Share by Pharmacological Effects (2021-2032)
Figure 59. World Afamelanotide Average Price by Pharmacological Effects (2021-2032) & (US$/Unit)
Figure 60. World Afamelanotide Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 61. World Afamelanotide Production Value Market Share by Application in 2025
Figure 62. Hematologic Disorders
Figure 63. Skin Pigmentary Disorders
Figure 64. Acute Diseases
Figure 65. Autoimmune Diseases
Figure 66. Neurodegenerative Diseases
Figure 67. World Afamelanotide Production Market Share by Application (2021-2032)
Figure 68. World Afamelanotide Production Value Market Share by Application (2021-2032)
Figure 69. World Afamelanotide Average Price by Application (2021-2032) & (US$/Unit)
Figure 70. Afamelanotide Industry Chain
Figure 71. Afamelanotide Procurement Model
Figure 72. Afamelanotide Sales Model
Figure 73. Afamelanotide Sales Channels, Direct Sales, and Distribution
Figure 74. Methodology
Figure 75. Research Process and Data Source
